this is the highest short % in over a yr....take notice.. i still like this company, but it will take time,,, Time is on shorts side for now
i agree, this is only a filing,, 100 mil financing is a known fact.. get it out of the way,, This will go much higher before actual dilution sets in,,,,,
it appears to me mm is taking advantage of low volume, ,He is selling small lots to keep price down,....Short % isn't a factor IMO
Any millionaire can easily manipulate a stock like SYN....These guys , who usually run hedge funds, work in tandem with market makers... Institutions buy dirt cheap and are usually in for the long haul. .Pennies mean nothing to them
I think you got it backward,, Retailers sold,and most likely some hedge fund, but institutions DID not sell...How about that fella that bought 1/4 million shares at 2.59 last month.... Did he sell ? nope
yep, thinking the same thing. Somebody bought at 2.22 and soon after a 50K ask price comes in at 2.23 ....Well, did you see the 90K blockade at 2.19..about 1/3rd of it was chewed away,, Shorts are making one last stand,....Short analytics show short % was way down today in comparison to past week,,, price is turning up
Many of you saw the jan call action for 2016,,insane amounts bought... Why do you think the calls were so cheap at 3-3.50 ? thoughts ?
that's all fine and dandy if money is what the shorts are after ? I still believe insulin companies are mainly behind this that don't want MNKD to succeed..
I think SNY is doing a small scale study right now to assess afrezza's success with patients/doctors....The reason they didn't do a full out launch is to take advantage of pps and buy out price..
typical biotech pattern,, run up into news and sell off on early trials....If we get partrnership with someone like SNY,, all bets off.. We keep climbing.....
interesting take ,,we know patient satisfaction seems good,,,It's the doc's who need to get on board